• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Disc Medicine, Inc. - Common Stock (NQ: IRON )

    45.59 +1.67 (+3.80%)
    Streaming Delayed Price Updated: 10:23 AM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 23,718
    Open 45.06
    Bid (Size) 45.52 (3)
    Ask (Size) 45.92 (2)
    Prev. Close 43.92
    Today's Range 44.03 - 46.43
    52wk Range 25.60 - 77.60
    Shares Outstanding 5,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    -23.67%
    -23.67%
    1 Month
    +2.43%
    +2.43%
    3 Month
    +71.91%
    +71.91%
    6 Month
    -27.98%
    -27.98%
    1 Year
    -1.08%
    -1.08%

    More News

    Read More
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Gold Gains 1%; US Consumer Sentiment Falls In June
    Via Benzinga
    Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Disc Medicine Announces Underwritten Offering of Common Stock
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine to Participate in the Jefferies Global Healthcare Conference
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
    From Disc Medicine Inc
    Via GlobeNewswire
    IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024
    Via InvestorPlace
    Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
    From Disc Medicine Inc
    Via GlobeNewswire
    Top 3 Health Care Stocks You'll Regret Missing This Month
    Via Benzinga
    Gold Gains 1%; CXApp Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Disc Medicine Stock Plunges As Light Sensitivity Treatment Data Confounded Due To Outsized Placebo Response
    Via Benzinga
    Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity Study
    Via Investor's Business Daily
    Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
    From Disc Medicine Inc
    Via GlobeNewswire
    Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal
    Via Talk Markets
    Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
    From Disc Medicine Inc
    Via GlobeNewswire
    Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
    From Disc Medicine Inc
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.